United Therapeutics | search
Click here to view United Therapeutics news from 60+ newspapers.
Bookmark or Share- United Therapeutics Announces World’s First Successful Xenothymokidney ...24 Apr 2024. United Therapeutics Announces World’s First Successful Xenothymokidney Transplant. The first living recipient of a UThymoKidney, in conjunction with a heart pump implant, is recovering after a successful transplantThis transplant builds on two successful UHeart transplants completed in 2022 and... Download pdf.
- United Therapeutics - WikipediaUnited Therapeutics Corporation is an American publicly traded biotechnology company and public benefit corporation listed on the NASDAQ under the symbol UTHR. It develops novel, life-extending technologies for patients in the areas of lung disease and organ manufacturing.
- About UTHR – United Therapeutics Investor RelationsContact IR. OUR mission and vision. At United Therapeutics, our mission and vision are one. We use our enthusiasm, creativity, and persistence to innovate for the unmet medical needs of our patients and to benefit our other stakeholders. We are bold and unconventional.
- United Therapeutics Announces FDA Approval and Launch of Tyvaso® for ...First and only approved therapy in the United States for patients with PH-ILD, a serious, life-threatening disease with potentially more than 30,000 patients in need FDA approval based on data ...
- United Therapeutics Investor RelationsUnited Therapeutics (Nasdaq: UTHR) seeks to travel down the corridors of indifference to develop treatments for rare, deadly diseases. We were founded in 1996 by a family seeking a cure for their daughter’s pulmonary arterial hypertension, or PAH. Today, we have six FDA-approved therapies that treat PAH, pulmonary hypertension associated with ...
More
